Letícia Rangel

Federal University of Espirito Santo

Leticia B. A. Rangel, Pharm.D., Ph.D., is an Associate Professor of the Department of Pharmaceutical Sciences and a member of the Biotechnology Program at the Federal University of Espirito Santo (UFES). As the head of the Laboratory of Cellular and Molecular Biology of Human Cancer, coordinates projects on ovarian cancer, breast, lung and kidney, with emphasis on the cellular and molecular mechanisms of these diseases, the development of biotechnology products and processes, and the discovery of new anticancer molecules. Her scientific network includes the Department of Chemistry (UFES), the Institute of Biophysics Carlos Chagas Filho (Federal University of Rio de Janeiro), the Division of Clinical Research of the Brazilian National Cancer Institute, The Department. of Molecular Medicine, University of Texas at San Antonio (USA), and the Department of Pathology at the Johns Hopkins University (USA), as well as the private sector. Aside from papers published on international journals, and ongoing patents negotiations, she has been awarded by the Brazilian government in recognition to her contribution in cancer research.

2books edited

5chapters authored

Latest work with IntechOpen by Letícia Rangel

Cancer Treatment: Conventional and Innovative Approaches is an attempt to integrate into a book volume the various aspects of cancer treatment, compiling comprehensive reviews written by an international team of experts in the field. The volume is presented in six sections: i) Section 1: Cancer treatment: Conventional and innovative pharmacological approaches; ii) Section 2: Combinatorial strategies to fight cancer: Surgery, radiotherapy, backytherapy, chemotherapy, and hyperthermia; iii) Section 3: The immunotherapy of cancer; iv) Section 4: Multidisciplinarity in cancer therapy: nutrition and beyond; v) Section 5: Supportive care for cancer patients; vi) Section 6: Perspectives in cancer biology and modeling. Ultimately, we hope this book can enlighten important issues involved in the management of cancer, summarizing the state-of-the-art knowledge regarding the disease control and treatment; thus, providing means to improve the overall care of patients that daily battle against this potentially lethal condition.

Go to the book